Cargando…

Vaccination Guidelines During and After the COVID-19 Epidemic in China

Detalles Bibliográficos
Autores principales:	Yu, Wenzhou, Li, Yuanqiu, Wu, Jing, Wang, Fuzhen, Wen, Ning, Rodewald, Lance, Hao, Lixin, Li, Yixing, Zheng, Hui, Li, Keli, Ma, Chao, Wu, Dan, Cao, Lei, Cao, Lingsheng, Ye, Jiakai, Liu, Yanmin, Zhang, Guomin, Du, Wen, An, Zhijie, Wang, Huaqing, Yin, Zundong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2020
Materias:	Policy Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422244/ https://www.ncbi.nlm.nih.gov/pubmed/34594733 http://dx.doi.org/10.46234/ccdcw2020.169

Ejemplares similares

Effectiveness of Catch-Up Vaccinations after COVID-19 Containment — China, 2020
por: Wu, Jing, et al.
Publicado: (2020)

Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China
por: An, Zhijie, et al.
Publicado: (2021)

Vaccine-preventable disease control in the People’s Republic of China: 1949–2016
por: Yu, Wenzhou, et al.
Publicado: (2018)

Senior Research Scholars in China CDC’s National Immunization Program
por: Wang, Miao, et al.
Publicado: (2021)

Effects of Three Major Immunization Interventions on Measles Control — China, 1952–2021
por: Song, Quanwei, et al.
Publicado: (2023)

Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
por: Wang, Fuzhen, et al.
Publicado: (2021)

Vaccination Vehicles for COVID-19 Immunization — China, 2021
por: Lei, Hong, et al.
Publicado: (2021)

Effectiveness of DTaP Against Pertussis in ≤2-Year-Old Children — Linyi Prefecture, Shandong Province, China, 2017–2019
por: Zhu, Pinpin, et al.
Publicado: (2023)

Progress Towards Hepatitis A Control and Prevention Through 2019: the National Immunization Program of China
por: Sun, Xiaojin, et al.
Publicado: (2020)

The National Immunization Advisory Committee in China: Roles of National Experts in Making Evidence-Based Recommendations for Immunization
por: Ma, Chao, et al.
Publicado: (2019)

“If the world doesn’t share the vaccine, the virus will take on the world”
por: Yin, Zundong, et al.
Publicado: (2021)

Vaccinate with Confidence and Finish Strong
por: Rodewald, Lance, et al.
Publicado: (2022)

Using a hepatitis B surveillance system evaluation in Fujian, Hainan, and Gansu provinces to improve data quality and assess program effectiveness, China, 2015
por: Zheng, Hui, et al.
Publicado: (2020)

Correction to: Using a hepatitis B surveillance system evaluation in Fujian, Hainan, and Gansu provinces to improve data quality and assess program effectiveness, China, 2015
por: Zheng, Hui, et al.
Publicado: (2020)

Progress Toward Measles Elimination — China, January 2013–June 2019
por: Ma, Chao, et al.
Publicado: (2019)

Progress Toward Measles Elimination — China, January 2013-June 2019
por: Ma, Chao, et al.
Publicado: (2019)

Impact of Influenza and Pneumococcal Polysaccharide Vaccination on Economic Burden from Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Hebei Province, China, November 2018 to November 2020
por: Li, Yan, et al.
Publicado: (2023)

Prioritization of Vaccines for Inclusion into China’s Expanded Program on Immunization: Evidence from Experts’ Knowledge and Opinions
por: Ma, Chao, et al.
Publicado: (2022)

Acute Hepatitis B — China, 2005−2019
por: Miao, Ning, et al.
Publicado: (2020)

Guidelines for diagnostic next-generation sequencing
por: Matthijs, Gert, et al.
Publicado: (2016)

European guidelines for constitutional cytogenomic analysis
por: Silva, Marisa, et al.
Publicado: (2018)

Effectiveness of Inactivated COVID-19 Vaccines Against Symptomatic, Pneumonia, and Severe Disease Caused by the Delta Variant: Real World Study and Evidence — China, 2021
por: Wu, Dan, et al.
Publicado: (2022)

Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021
por: Ma, Chao, et al.
Publicado: (2022)

EMQN best practice guidelines for genetic testing in dystrophinopathies
por: Fratter, Carl, et al.
Publicado: (2020)

Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group
por: Riechelmann, Rachel P, et al.
Publicado: (2017)

Brazilian Group of Gastrointestinal Tumours’ consensus guidelines for the management of oesophageal cancer
por: Rocha-Filho, Duilio R, et al.
Publicado: (2021)

International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines
por: de Campos Vieira Abib, Simone, et al.
Publicado: (2022)

Genetic testing for mitochondrial disease: the United Kingdom best practice guidelines
por: Mavraki, Eleni, et al.
Publicado: (2022)

Understanding the Epidemic Course in Order to Improve Epidemic Forecasting
por: Jia, Peng
Publicado: (2020)

A note on the effects of epidemic forecasts on epidemic dynamics
por: Record, Nicholas R., et al.
Publicado: (2020)

EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease
por: Losekoot, Monique, et al.
Publicado: (2013)

EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH)
por: Porto, Graça, et al.
Publicado: (2016)

Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2
por: Kamsteeg, Erik-Jan, et al.
Publicado: (2012)

EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
por: Baumgartner-Parzer, Sabina, et al.
Publicado: (2020)

EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies
por: Traeger-Synodinos, Joanne, et al.
Publicado: (2015)

The improvement of the best practice guidelines for preimplantation genetic diagnosis of cystic fibrosis: toward an international consensus
por: Girardet, Anne, et al.
Publicado: (2016)

Update of the EMQN/ACGS best practice guidelines for molecular analysis of Prader-Willi and Angelman syndromes
por: Beygo, Jasmin, et al.
Publicado: (2019)

Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China
por: Cui, Fuqiang, et al.
Publicado: (2017)

Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Chronic Obstructive Pulmonary Disease — Hebei Province, China, September−December, 2019
por: Li, Yan, et al.
Publicado: (2021)

Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial
por: Wang, Yamin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_itkjhhls26mtjpmsoacssk5e6s